Company Filing History:
Years Active: 1996
Title: Mark Bures - Innovator in Alkaline Phosphatase Inhibitors
Introduction
Mark Bures is a notable inventor based in Lake Zurich, Illinois. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as alkaline phosphatase inhibitors. His work has implications for various therapeutic applications, including cancer treatment and mental health.
Latest Patents
Mark Bures holds a patent for "Compounds useful as alkaline phosphatase inhibitors and therapeutic agents." This invention discloses novel compounds that selectively inhibit human alkaline phosphatases, distinguishing them from Escherichia coli alkaline phosphatases. The compounds can be utilized as cancer therapeutic agents, anti-depressive agents, anti-anergic agents, and antihelminthic agents. The general formula of these compounds includes various substituents, allowing for a range of applications in therapeutic settings. He has 1 patent to his name.
Career Highlights
Mark Bures is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on innovative solutions that address critical health challenges. His research has contributed to the advancement of therapeutic agents that can improve patient outcomes.
Collaborations
Mark has collaborated with esteemed colleagues such as Mazhar Husain and Dominique Bridon. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic compounds.
Conclusion
Mark Bures is a distinguished inventor whose work in developing alkaline phosphatase inhibitors has the potential to impact various therapeutic areas. His contributions to Abbott Laboratories Corporation and collaborations with fellow researchers underscore his commitment to advancing medical science.